These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 30841447)

  • 1. Hypomethylated gene NRP1 is co-expressed with PDGFRB and associated with poor overall survival in gastric cancer patients.
    Wang G; Shi B; Fu Y; Zhao S; Qu K; Guo Q; Li K; She J
    Biomed Pharmacother; 2019 Mar; 111():1334-1341. PubMed ID: 30841447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinformatics-Based Identification of Methylated-Differentially Expressed Genes and Related Pathways in Gastric Cancer.
    Li H; Liu JW; Liu S; Yuan Y; Sun LP
    Dig Dis Sci; 2017 Nov; 62(11):3029-3039. PubMed ID: 28914394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinformatic analysis of the prognostic value of ZNF860 in recurrence-free survival and its potential regulative network in gastric cancer.
    Pan HX; Bai HS; Guo Y; Cheng ZY
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):162-170. PubMed ID: 30767193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Validation of a Prognostic Nomogram for Gastric Cancer Based on DNA Methylation-Driven Differentially Expressed Genes.
    Bai Y; Wei C; Zhong Y; Zhang Y; Long J; Huang S; Xie F; Tian Y; Wang X; Zhao H
    Int J Biol Sci; 2020; 16(7):1153-1165. PubMed ID: 32174791
    [No Abstract]   [Full Text] [Related]  

  • 5. A novel scoring system for gastric cancer risk assessment based on the expression of three CLIP4 DNA methylation-associated genes.
    Hu C; Zhou Y; Liu C; Kang Y
    Int J Oncol; 2018 Aug; 53(2):633-643. PubMed ID: 29901187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation signatures associated with prognosis of gastric cancer.
    Dai J; Nishi A; Li ZX; Zhang Y; Zhou T; You WC; Li WQ; Pan KF
    BMC Cancer; 2021 May; 21(1):610. PubMed ID: 34034702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrative analysis of DNA methylation and gene expression through machine learning identifies stomach cancer diagnostic and prognostic biomarkers.
    Hosseini M; Lotfi-Shahreza M; Nikpour P
    J Cell Mol Med; 2023 Mar; 27(5):714-726. PubMed ID: 36779430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GLI2 induces PDGFRB expression and modulates cancer stem cell properties of gastric cancer.
    Wang JX; Zhou JF; Huang FK; Zhang L; He QL; Qian HY; Lai HL
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3857-3865. PubMed ID: 28975979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methylation profiling identifies epigenetic signatures of early gastric cancer.
    Shi Z; Guo X; Hu X; Li R; Li X; Lu J; Jin M; Jiang X
    Virchows Arch; 2024 Apr; 484(4):687-695. PubMed ID: 38507065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PDGFRB is a potential prognostic biomarker and correlated with immune infiltrates in gastric cancer.
    Liu B; Xiao X; Lin Z; Lou Y; Zhao L
    Cancer Biomark; 2022; 34(2):251-264. PubMed ID: 34958001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatics-based analysis of the association between the A1-chimaerin (
    Li JP; Zeng SH; Zhang YH; Liu YJ
    Bioengineered; 2021 Dec; 12(1):2874-2889. PubMed ID: 34152250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a Tumor Microenvironment-relevant Gene set-based Prognostic Signature and Related Therapy Targets in Gastric Cancer.
    Cai WY; Dong ZN; Fu XT; Lin LY; Wang L; Ye GD; Luo QC; Chen YC
    Theranostics; 2020; 10(19):8633-8647. PubMed ID: 32754268
    [No Abstract]   [Full Text] [Related]  

  • 13. High expression of WTAP leads to poor prognosis of gastric cancer by influencing tumour-associated T lymphocyte infiltration.
    Li H; Su Q; Li B; Lan L; Wang C; Li W; Wang G; Chen W; He Y; Zhang C
    J Cell Mol Med; 2020 Apr; 24(8):4452-4465. PubMed ID: 32176425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 5-Gene Prognostic Combination for Predicting Survival of Patients with Gastric Cancer.
    Song L; Wang XY; He XF
    Med Sci Monit; 2019 Aug; 25():6313-6320. PubMed ID: 31422414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-Scale Analysis Identified NID2, SPARC, and MFAP2 as Prognosis Markers of Overall Survival in Gastric Cancer.
    Shan Z; Wang W; Tong Y; Zhang J
    Med Sci Monit; 2021 Mar; 27():e929558. PubMed ID: 33758160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of sorting nexin 10 weak expression in stomach adenocarcinoma revealed by weighted gene co-expression network analysis.
    Zhang J; Wu Y; Jin HY; Guo S; Dong Z; Zheng ZC; Wang Y; Zhao Y
    World J Gastroenterol; 2018 Nov; 24(43):4906-4919. PubMed ID: 30487700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
    Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
    Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation status of TRAF2 is associated with the diagnosis and prognosis of gastric cancer.
    Zhang J; Dai WJ; Yang XZ
    Int J Clin Exp Pathol; 2015; 8(11):14228-34. PubMed ID: 26823737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and prognostic value of
    Wang MQ; Yin QY; Chen YR; Zhu SL
    Future Oncol; 2021 Dec; 17(35):4907-4923. PubMed ID: 34751593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diversity of clinical implication of B-cell translocation gene 1 expression by histopathologic and anatomic subtypes of gastric cancer.
    Kanda M; Oya H; Nomoto S; Takami H; Shimizu D; Hashimoto R; Sueoka S; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Dig Dis Sci; 2015 May; 60(5):1256-64. PubMed ID: 25487193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.